Sergio Muñoz-Martínez

8PUBLICATIONS
58CO-AUTHORS
Cellular immunologyMetabolic medicinePredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
Immunotherapy Rechallenge in HCC: A Second Chance for Response?

|Dec 09, 2023
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.

Jesús Rivera-Esteban, Alba Jiménez-Masip, Sergio Muñoz-Martínez

|Jul 14, 2023
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.

Sergio Muñoz-Martínez, Victor Sapena, Ángeles García-Criado

|Jan 12, 2023
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis.

Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena

|May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.

Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner

|Jul 06, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.

Álvaro Díaz-González, Víctor Sapena, Loreto Boix

Pageof 2

Frequent Collaborators

5 joint publications

Alejandro Forner

5 joint publications

Victor Sapena

4 joint publications

María Reig

3 joint publications

José Ríos